Novozymes A/S
F:NZM
Novozymes A/S
F:NZM
Price:
55
EUR
-0.9%
Market Cap:
€25.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novozymes A/S
F:NZM
|
DK |
|
A
|
Asian Alliance International PCL
SET:AAI
|
TH |
|
Fox Corp
F:FO5B
|
US |
|
P
|
Pilgrims Pride Corp
F:6PP
|
US |
|
E
|
Essex Property Trust Inc
F:EXP
|
US |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM's stock price target?
Not Available
NZM does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
